Stockscreener 앱 받기
1.28
4.48%
-0.06
시간 외 거래:
1.30
0.02
+1.56%
전일 마감가:
$1.34
열려 있는:
$1.31
하루 거래량:
848.40K
Relative Volume:
0.68
시가총액:
$167.81M
수익:
$4.40M
순이익/손실:
$-53.29M
주가수익비율:
-1.427
EPS:
-0.897
순현금흐름:
$-44.18M
1주 성능:
-7.91%
1개월 성능:
-7.25%
6개월 성능:
+17.43%
1년 성능:
-14.67%
1일 변동 폭
$1.25
$1.33
1주일 범위
$1.25
$1.43
52주 변동 폭
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.28 | 175.67M | 4.40M | -53.29M | -44.18M | -0.897 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics (LUCD) Expected to Announce Earnings on Thursday - MarketBeat
Inogen (INGN) soars 6.6%: Is further upside left in the stock? - MSN
Aug Breakouts: Can Lucid Diagnostics Inc lead its sector in growthDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Lucid Diagnostics dips after pricing $25M stock offering - MSN
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
2,960,066 Shares in Lucid Diagnostics Inc. $LUCD Acquired by Ghisallo Capital Management LLC - MarketBeat
Lucid Diagnostics (NASDAQ:LUCD) Cut to "Sell" at Wall Street Zen - MarketBeat
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Decliners Report: Whats the MACD signal for Lucid Diagnostics Inc2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Price Action: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Risk Recap: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Breakouts Watch: Can Lucid Diagnostics Inc expand into new marketsVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
LUCD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to “Hold” at Wall Street Zen - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to "Hold" at Wall Street Zen - MarketBeat
LUCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Downgrade Watch: Is Lucid Diagnostics Inc likely to announce a buybackDay Trade & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Lucid Diagnostics CEO granted 2.17M restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) receives 123,000-share restricted stock grant - Stock Titan
123K-share equity grant to Lucid Diagnostics (LUCD) director Debra White vests 2029 - Stock Titan
Lucid director granted 123,000 restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) awarded 123,000 restricted shares - Stock Titan
Director at Lucid Diagnostics (LUCD) granted 123K restricted shares - Stock Titan
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity - Stock Titan
Director at Lucid Diagnostics (NASDAQ: LUCD) receives 123,000-share restricted stock grant - Stock Titan
Lucid Diagnostics (LUCD) CFO granted 470,000 restricted shares vesting in 2029 - Stock Titan
Lucid Diagnostics (LUCD) COO awarded 620,000 restricted shares in Form 4 filing - Stock Titan
Lucid Diagnostics (LUCD) awards 300,000 restricted shares to General Counsel - Stock Titan
Aberdeen Group plc Invests $2.53 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Aug Decliners: Is Lucid Diagnostics Inc likely to announce a buybackJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):